• OncoAssureā„¢ Prostate Cancer Gene Expression Panel
  • Chromosome Analysis, Hematologic Disorders, Blood
  • Angiotensin Converting Enzyme (ACE), Serum/Plasma
  • Phenobarbital, Serum or Plasma
  • Heparin induced thrombocytopenia
  • TYMS (Thymidylate Synthetase) Gene Mutation Analysis
  • Leptospirosis
  • Carnitine Palmitoyltransferase 1A (CPT1A) Mutation Analysis
  • Vitamin B2 (Riboflavin) deficiency
  • 5-Hydroxyindoleacetic Acid (5-HIAA), Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection
Medical Test

Interpretation
Access to MyProstateScore 2.0 (MPS2) for Prostate Cancer Early Detection is restricted.
Loading...